MDA Venture Philanthropy Grant Contract Between Muscular Dystrophy Association, Inc. and Summit Corporation plc (for the development of DMD and/or BMD therapeutics)Reviewer Confidentiality Agreement • January 30th, 2015 • Summit Corp PLC • Pharmaceutical preparations • New York
This MDA Venture Philanthropy Corporate Grant Contract (“Contract”) is entered into as of December 15, 2011 (the “Effective Date”), between Muscular Dystrophy Association, Inc., a New York not-for-profit corporation (“MDA”) and Summit Corporation plc, a company incorporated in England and listed on the Alternative Investment Market of the London Stock Exchange having its registered office at 91 Milton Park, Abingdon, Oxfordshire, OX14 4RY, England (“GRANTEE”), to document the terms upon which MDA will provide funding for the Project (as defined below) and certain related matters. MDA and GRANTEE are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
